What the sentiment indicator is Signaling: Gilead Sciences Inc. (GILD) Stock

GILD Stock

Currently, the biotechnology firm Gilead Sciences Inc. (NASDAQ: GILD)’s major sources of revenue are HIV therapy medications and COVID-19. However, Gilead Sciences Inc. (GILD) experienced issues in both markets: first, the firm lost patent protection for several HIV medications, and subsequently, intense competition and diminishing infections placed pressure on sales of the COVID-19 therapy. Gilead […]